Company News
Solara Schedules Q2 FY27 Results Conference Call
Solara Active Pharma Sciences intimated exchanges about an upcoming analyst/investor conference call.
The call scheduled for October 16, 2026, will discuss unaudited Q2 and H1 FY27 financial results.
